Dr. Justin Tyler Sybesma, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 183 Peace Blvd, Saint Joseph, MI 49085 Phone: 269-428-3500 Fax: 269-429-6429 |
Dr. James R Burczak, D.O. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 183 Peace Blvd, Saint Joseph, MI 49085 Phone: 269-428-3500 |
Dr. Kenneth J Edwards, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 183 Peace Blvd, Saint Joseph, MI 49085 Phone: 269-428-3500 |
Dr. Joseph Adam Farber, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 183 Peace Blvd, Saint Joseph, MI 49085 Phone: 269-428-3500 |
Dr. Daniel G. Sohn, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 183 Peace Blvd, Saint Joseph, MI 49085 Phone: 269-428-3500 |
News Archive
Chronic, frequent tobacco smokers have a decreased number of cannabinoid CB1 receptors, the "pot receptor", when compared with non-smokers, reports a study in Biological Psychiatry.
Transmissible spongiform encephalopathies (TSEs), or prion diseases, are a family of rare progressive, neurodegenerative illnesses that affect both humans and animals. TSE surveillance is important for public health and food safety because TSEs have the potential of crossing from animals to humans, as seen with the spread of mad cow disease, or bovine spongiform encephalopathy (BSE). A study in The Journal of Molecular Diagnostics describes an advanced assay that offers better sensitivity than currently available tests for detecting a prion disease affecting elk.
Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced the acquisition of worldwide rights to a biogeneric version of filgrastim and an affiliated European manufacturing facility from PLIVA Hrvatska d.o.o. (Zagreb, Croatia) (ZSE: PLVA-R-A), a move that will help extend Hospira's reach and vertical integration in biogenerics. Financial terms of the agreement were not disclosed.
Cancer and open-heart surgery patients, disaster victims, organ or bone marrow transplant recipients, and others who require life-saving blood platelet transfusions will benefit from equipment invented by a researcher at the University of British Columbia's Centre for Blood Research (CBR).
› Verified 2 days ago